Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +10.42%
#3 would would +6.86%
#4 Hive Hive +6.25%
#5 WAX WAX +5.69%
#6 Pons Pons +4.94%
#7 The Bitcoin Bull The Bitcoin Bull +4.43%
#8 OpenAI (Republic Pre-IPO) OpenAI (Republic Pre-IPO) +4.16%
#9 edgeX edgeX +3.72%
#10 Ribbita by Virtuals Ribbita by Virtuals +3.31%
Coin of the day
Palladium Network Palladium Network
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Classificação em ações #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Preço da ação
$5.84
Última sincronização: 2025-04-02
Valor de mercado
$224.09M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Nevro Corp. (NVRO)

Categoria

Healthcare
Receita da Nevro Corp. (NVRO)
Receita em Dec 2024 TTM: $408.52M
De acordo com os últimos relatórios financeiros da Nevro Corp., a receita atual da empresa (TTM) é $408.52M. Em 2023, a empresa obteve uma receita de $425.17M um aumento em relação a a receita do ano 2022, que foi de $406.37M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Nevro Corp. de 2012 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $408.52M 0.00%
2024 $408.52M -3.92%
2023 $425.17M 4.63%
2022 $406.37M 5.03%
2021 $386.91M 6.87%
2020 $362.05M -7.23%
2019 $390.26M 0.77%
2018 $387.29M 18.56%
2017 $326.67M 42.96%
2016 $228.50M 228.28%
2015 $69.61M 113.69%
2014 $32.57M 38.61%
2013 $23.50M 29.48%
2012 $18.15M 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 11,303.41%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 6,224.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 8,586.03%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 5,039.55%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 1,494.13%
US